Piramal Pharma Ltd.

View in App
125.25 +1.65 ▲1.3%

30 November 2023, 12:21:58 PM
Volume: 3,183,545

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.piramal.com
Market Cap 16,311.64 Cr.
Enterprise Value(EV) 20,206.12 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.01 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.14 Trailing Twelve Months Ending 2023-09
Book Value / Share 58.64 Trailing Twelve Months Ending 2023-09
Price to Book Value 2.10 Calculated using Price: 123.30
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 132.29 Cr. 1,322,923,098 Shares
FaceValue 10
About Piramal Pharma Ltd.
The company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across many global facilities and a global distribution network in hundreds of countries. It includes PPS, PCC and the India Consumer Healthcare business, selling over-the-counter products.

Piramal Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Piramal Pharma Ltd. Performance

View details >>
1 Day
+1.33%
1 Week
+5.16%
1 Month
+35.41%
3 Month
+25.82%
6 Month
+56.21%
1 Year
-5.49%
2 Year
5 Year
10 Year

Piramal Pharma Ltd. Fundamental Ratios

View details >>
3 years 2021-03 2022-03 2023-03
Return on Equity (%) 14.90 6.11 -2.77
Return on Capital Employed (%) 13.06 7.10 1.95
Return on Assets (%) 7.76 3.20 -1.37

Piramal Pharma Ltd. Balance Sheet

View details >>
Particulars 4 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5,605 6,697 6,774 7,758
Non Curr. Liab. 2,560 2,903 3,812 3,032
Curr. Liab. 2,591 3,118 3,851 3,597
Minority Int.
Equity & Liab. 10,756 12,717 14,437 14,386
Non Curr. Assets 7,007 8,565 9,593 9,432
Curr. Assets 3,749 4,152 4,843 4,954
Misc. Exp. not W/O
Total Assets 10,756 12,717 14,437 14,386

Piramal Pharma Ltd. Profit and Loss

View details >>
Particulars 4 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 6,315 6,559 7,082 7,540
Other Income 164 276 225 195
Total Income 6,479 6,835 7,307 7,734
Total Expenditure -4,887 -5,609 -6,453 -6,703
PBIDT 1,592 1,225 853 1,031
Interest -163 -198 -344 -427
Depreciation -545 -586 -677 -707
Taxation -114 -109 -66 -87
Exceptional Items 18 -15 -7
PAT 835 376 -186 -190
Minority Interest
Share Associate 57
Other Related Items
Consolidated Net Profit 835 376 -186 -134
Adjusted EPS 8 3 -2 -1

Piramal Pharma Ltd. Cash Flow

View details >>
Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 598 766 484
Cash Fr. Inv. -4,480 -1,812 -1,339
Cash Fr. Finan. 3,977 794 818
Net Change 94 -251 -37
Cash & Cash Eqvt 262 85 53

Piramal Pharma Ltd. Shareholding Pattern

View details >>
5 Qtrs 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 34.79 34.79 34.79 34.79 35.02
Public 65.21 65.21 65.21 65.21 64.98
Depository Receipts 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00

Piramal Pharma Ltd. Announcements

View details >>
Tue, 28 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Piramal Pharma Limited has informed the Exchange about Schedule of meet
Wed, 22 Nov 2023
Updates
Piramal Pharma Limited has informed the Exchange regarding 'Details of Litigation as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI Listing Regulations )'.
Wed, 22 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Piramal Pharma Limited has informed the Exchange about Schedule of meet

Piramal Pharma Ltd. Technical Scans

View details >>
Wed, 29 Nov 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Piramal Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 288,124.14 1,207.15 +0.4%
Divi's Laboratories Ltd. 98,985.27 3,791.90 +1.7%
Cipla Ltd. 97,035.44 1,200.10 -0.1%
Dr. Reddy's Laboratories Ltd. 95,335.50 5,760.55 +0.8%
Apollo Hospitals Enterprise Ltd. 77,919.78 5,513.30 +1.7%
Mankind Pharma Ltd. 76,041.70 1,899.65 +0.1%
Torrent Pharmaceuticals Ltd. 70,779.09 2,116.85 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 33.70 1,207.15 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 74.33 3,791.90 +1.7%
Cipla Ltd. Consolidated 2023-09 28.10 1,200.10 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.73 5,760.55 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 111.72 5,513.30 +1.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.32 1,899.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.06 2,116.85 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.82 1,207.15 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.81 3,791.90 +1.7%
Cipla Ltd. Consolidated 2023-09 3.91 1,200.10 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.74 5,760.55 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 11.99 5,513.30 +1.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.02 1,899.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.55 2,116.85 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,207.15 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,791.90 +1.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,200.10 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,760.55 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,513.30 +1.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,899.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,116.85 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,207.15 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,791.90 +1.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,200.10 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,760.55 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,513.30 +1.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,899.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,116.85 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,207.15 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,791.90 +1.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,200.10 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,760.55 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,513.30 +1.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,899.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,116.85 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,207.15 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,791.90 +1.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,200.10 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,760.55 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,513.30 +1.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,899.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,116.85 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,207.15 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,791.90 +1.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,200.10 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,760.55 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,513.30 +1.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,899.65 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,116.85 +1.2%

Piramal Pharma Ltd. FAQ's

What is Piramal Pharma share price?
Can I buy Piramal Pharma shares now?
What is the Market Cap of Piramal Pharma?
What are the key metrics to analyse Piramal Pharma?
What is the 52 Week High and Low of Piramal Pharma?
What is the trend of Piramal Pharma share price?